Sakar Healthcare Limited

NSE SAKAR.NS

Sakar Healthcare Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD 3.29 M

Sakar Healthcare Limited Net Cash Used Provided By Financing Activities is USD 3.29 M for the year ending March 31, 2024, a -34.20% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Sakar Healthcare Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD 5.00 M, a -30.49% change year over year.
  • Sakar Healthcare Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD 7.19 M, a 64.43% change year over year.
  • Sakar Healthcare Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD 4.37 M, a 847.08% change year over year.
  • Sakar Healthcare Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD 461.92 K, a -44.55% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
SV Wall Street
NSE: SAKAR.NS

Sakar Healthcare Limited

CEO Mr. Sanjay Surendra Shah
IPO Date March 16, 2017
Location India
Headquarters 406, Silver Oaks Comm. Complex
Employees 325
Sector Healthcare
Industries
Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care Plastics
Description

Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.

StockViz Staff

February 9, 2025

Any question? Send us an email